Home

COVID-19 Vaccine Resources

Date Published	Source	Title/Link/Description
9/26/22	Pfizer	Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster in Children 5 Through 11 Years of Age
9/8/22	White House	Biden Administration Outlines Plan to Get Americans an Updated COVID-⁠19 Vaccine Shot and Manage COVID-⁠19 this Fall
9/6/22	CDC	COVID-19 Vaccination Schedule for Most People
9/2/22	CDC	Booster Tool
9/1/22	CDC	CDC Recommends the First Updated COVID-19 Booster
8/31/22	FDA	FDA Authorizes Moderna, Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose
8/22/22	CDC	CDC Recommends Novavax COVID-19 Vaccine for Adolescents
8/16/22	CDC	CDC Fall Vaccination Operational Planning Guide – Information for the Fall Vaccine Campaign, Including Upcoming Bivalent COVID-19 Vaccine Booster Doses
7/29/22	CDC	CDC Says Vaccine Reactions Less Frequent After Fourth Dose
6/30/22	FDA	FDA Recommends Inclusion of Omicron BA.4/5 Component for COVID-19 Vaccine Booster Doses
6/17/22	FDA	Coronavirus (COVID-19) Update: FDA Authorizes Moderna and Pfizer-BioNTech COVID-19 Vaccines for Children Down to 6 Months of Age
6/9/22	White House	FACT SHEET: Biden Administration Announces Operational Plan for COVID-⁠19 Vaccinations for Children Under 5
5/5/22	FDA	FDA Limits Use of Janssen COVID-19 Vaccine to Certain Individuals
4/6/22	CMS	Eligible Individuals Can Receive Second COVID-19 Booster Shot at No Cost
1/5/22	CDC	CDC Expands Booster Shot Eligibility and Strengthens Recommendations for 12-17 Year Olds
1/3/22	FDA	FDA Expands Use of Pfizer-BioNTech COVID-19 Vaccine-Boosters for Individuals 12 through 15
12/8/21	FDA	FDA Expands Eligibility for Pfizer-BioNTech COVID-19 Booster Dose to 16- and 17-Year-Olds
11/29/21	CDC	COVID-19 Vaccine Booster Shots
11/9/21	Pfizer	Pfizer and BioNTech Submit Request to Amend FDA EUA of COVID-19 Vaccine Booster to Include All Individuals 18 and Older
11/9/21	HHS	U.S. Surgeon General Releases New Community Toolkit for Addressing Health Misinformation
11/2/21	CDC	CDC Recommends Pediatric Pfizer COVID-19 Vaccine for Children 5 to 11 Years
10/13/21	NIH	Heterologous SARS-CoV-2 Booster Vaccinations – Preliminary Report
9/30/21	HHS	Guidance on HIPAA, COVID-19 Vaccinations, and the Workplace
9/29/21	CDC	Health Alert Network: COVID-19 Vaccination for Pregnant People to Prevent Serious Illness, Deaths, and Adverse Pregnancy Outcomes from COVID-19
9/28/21	CDC	Safety Monitoring of an Additional Dose of COVID-19 Vaccine — United States, August 12–September 19, 2021
9/24/21	CDC	CDC Statement on ACIP Booster Recommendations
9/22/21	FDA	FDA Authorizes Booster Dose of Pfizer-BioNTech COVID-19 Vaccine for Certain Populations
9/21/21	Johnson & Johnson	Johnson & Johnson Announces Real-World Evidence and Phase 3 Data Confirming Strong and Long-Lasting Protection of Single-Shot COVID-19 Vaccine in the U.S.
8/23/21	FDA	FDA Approves First COVID-19 Vaccine
8/18/21	HHS	Joint Statement from HHS Public Health and Medical Experts on COVID-19 Booster Shots
8/13/21	CDC	Updated Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Authorized in the United States
8/12/21	FDA	FDA Authorizes Additional Vaccine Dose for Certain Immunocompromised Individuals
8/6/21	CDC	New CDC Study: Vaccination Offers Higher Protection than Previous COVID-19 Infection
7/29/21	White House	Fact Sheet: President Biden to Announce New Actions to Get More Americans Vaccinated and Slow the Spread of the Delta Variant
7/28/21	FDA	FDA Extends Expiration of Johnson & Johnson Vaccine to Six Months
7/27/21	CDC	Vaccination to Prevent COVID-19 Outbreaks with Current and Emergent Variants
7/27/21	CDC	Guidance for Implementing COVID-19 Prevention Strategies in the Context of Varying Community Transmission Levels and Vaccination Coverage
7/27/21	HHS, HRSA	Administration Provides $121 Million in American Rescue Plan Funds to Support Local Community-Based Efforts to Increase COVID-19 Vaccinations in Underserved Communities
7/12/21	FDA	Updated Fact Sheet for Recipients and Caregivers (Janssen COVID-19 Vaccine)
7/12/21	FDA	Updated Authorized Fact Sheet for Healthcare Providers Administering Janssen Vaccine
6/23/21	NIH	NIH begins study of COVID-19 vaccination during pregnancy and postpartum
6/9/21	HHS	Letter from HHS Secretary Xavier Becerra to Insurers & Providers: COVID-19 Vaccines and Testing Must be Free for Patients
6/9/21	CMS	Increased Payments for At-Home COVID-19 Vaccinations for Medicare Beneficiaries
6/8/21	CDC	Increasing Access to Vaccination Opportunities: COVID-19 Vaccination upon Discharge from Hospitals, Emergency Departments, and Urgent Care Facilities
6/2/21	White House	FACT SHEET: President Biden to Announce National Month of Action to Mobilize an All-of-America Sprint to Get More People Vaccinated by July 4th
6/1/21	Moderna	Moderna Announces Initiation of Rolling Submission of Biologics License Application (BLA) with U.S. FDA for the Moderna COVID-19 Vaccine
5/28/21	CMS	COVID-19 Vaccine Update For Adolescents Aged 12-15 Years
5/28/21	EEOC	EEOC Issues Updated COVID-19 Technical Assistance
5/27/21	HHS	COVID-19 Guidance for Hospital Reporting and FAQs For Hospitals, Hospital Laboratory, and Acute Care Facility Data Reporting (Updated)
5/27/21	HHS, OMH	COVID-19 Vaccines and Racial and Ethnic Minority Populations (Toolkit/Resource)
5/25/21	Moderna	Moderna Announces TeenCOVE Study of its COVID-19 Vaccine in Adolescents Meets Primary Endpoint and Plans to Submit Data to Regulators in Early June
5/19/21	FDA	FDA Authorizes Longer Time for Refrigerator Storage of Thawed Pfizer-BioNTech COVID-19 Vaccine Prior to Dilution
5/19/21	FDA	FDA Authorizes Longer Time for Refrigerator Storage of Thawed Pfizer-BioNTech COVID-19 Vaccine Prior to Dilution
5/19/21	FDA	FDA Safety Communication: Antibody Testing Is Not Currently Recommended to Assess Immunity After COVID-19 Vaccination
5/13/21	CMS	Updated Interim Public Health Recommendations for Fully Vaccinated People
5/12/21	CDC	CDC Director Statement on Pfizer’s Use of COVID-19 Vaccine in Adolescents Age 12 and Older
5/10/21	FDA	FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Adolescents (12-15 Years Old)
5/5/21	HHS/HUD	HHS Secretary Becerra, HUD Secretary Fudge Announce Joint Effort to Increase Access to COVID-19 Vaccinations
5/3/21	HRSA	COVID-19 Coverage Assistance Fund
5/3/21	HHS	HHS Launches New Reimbursement Program for COVID-19 Vaccine Administration Fees not Covered by Insurance
4/27/21	FDA	Janssen COVID-19 Vaccine Frequently Asked Questions
4/27/21	CDC	Interim Public Health Recommendations for Fully Vaccinated People
4/23/21	CDC/FDA	FDA and CDC Lift Recommended Pause on Johnson & Johnson (Janssen) COVID-19 Vaccine Use Following Thorough Safety Review
4/15/21	HHS-OIG	Message from HHS-OIG Leadership on the COVID-19 Vaccination Program and Provider Compliance
4/15/21	HHS	COVID-19 Vaccine Fact Sheet for Patients/Providers (English and Spanish)
4/14/21	GAO	Report on Efforts to Increase Vaccine Availability and Perspectives on Initial Implementation
4/13/21	CDC/FDA	Joint CDC and FDA Statement on Johnson & Johnson COVID-19 Vaccine
4/7/21	FEMA	Expansion of COVID-19 Vaccine Program to All Community Health Centers
4/1/21	FDA	Coronavirus (COVID-19) Update: FDA Makes Two Revisions to Moderna COVID-19 Vaccine Emergency Use Authorization to Help Increase the Number of Vaccine Doses Available
4/1/21	HHS	HHS Launches COVID-19 Community Corps as Trusted Voices in Next Phase of COVID-19 Public Education Campaign
3/29/21	FEMA	First Mobile Vaccination Units in U.S. to Open in Maryland
3/29/21	CDC	Interim Estimates of COVID-19 Vaccine Effectiveness in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021
3/23/21	NIH	NIAID Statement on AstraZeneca Vaccine
3/22/21	NIH	Investigational AstraZeneca vaccine prevents COVID-19
3/17/21	CDC	County-Level COVID-19 Vaccination Coverage and Social Vulnerability
3/15/21	CMS	Biden-Harris Administration Increases Medicare Payment for Life-Saving COVID-19 Vaccine
3/12/21	HHS	HHS amends PREP Act declaration to increase COVID-19 vaccine workforce
3/10/21	CDC	Updated Healthcare Infection Prevention and Control Recommendations in Response to COVID-19 Vaccination
3/8/21	CDC	Interim Public Health Recommendations for Fully Vaccinated People
3/2/21	HHS	Biden Administration Announces Historic Manufacturing Collaboration Between Merck and Johnson & Johnson to Expand Production of COVID-19 Vaccines
2/28/21	CDC	Media Statement from CDC Director Rochelle P. Walensky, MD, MPH, on Signing the Advisory Committee on Immunization Practices’ Recommendation to Use Janssen’s COVID-19 Vaccine in People 18 and Older
2/27/21	FDA	FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine (Janssen)
2/26/21	DOL; Dept. of Treasury	FAQs About Families First Coronavirus Response Act and CARES Act Implementation Part 44
2/19/21	CDC	First Month of COVID-19 Vaccine Safety Monitoring — United States, December 14, 2020–January 13, 2021
2/17/21	OIG	FAQs – Application of OIG’s Administrative Enforcement Authorities to Arrangements Directly Connected to the Coronavirus Disease 2019 (COVID-19) Public Health Emergency
2/11/21	CDC	Vaccinating Homebound Persons With COVID-19 Vaccine
2/9/21	CDC	COVID-19 Vaccination Intent, Perceptions, and Reasons for Not Vaccinating Among Groups Prioritized for Early Vaccination — United States, September and December 2020
2/4/21	FDA	Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss Janssen Biotech Inc.’s COVID-19 Vaccine Candidate
2/3/21	NASEM	Strategies for Building Confidence in the COVID-19 Vaccines
2/2/21	CDC	HHS COVID-19 Portal – FAQs Vaccination Data
2/2/21	CDC	Federal Retail Pharmacy Partnership Program for COVID-19 Vaccination FAQs
1/28/21	FEMA	FEMA Supports Vaccine Distribution: COVID-19 Response Update
1/27/21	HHS	Amendment to Public Readiness and Emergency Preparedness Act (PREP Act) to permit retired and inactive clinicians to administer COVID-19 vaccines
1/27/21	CDC	Importance of COVID-19 Vaccination for Essential Workers
1/21/21	CDC	Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in the United States
1/19/21	CMS	AMA Announces Update to COVID-19 Vaccine CPT® (Janssen) Codes
1/19/21	OCR	Enforcement Discretion Regarding Online or Web-Based Scheduling Applications for the Scheduling of Individual Appointments for COVID-19 Vaccination
1/16/21	CDC	COVID-19 Vaccine Communication Toolkit for Essential Workers
1/16/21	CDC	COVID-19 Vaccine Communication Toolkit for Community-Based Organizations
1/7/21	CDC	Vaccination Considerations for People who are Pregnant or Breastfeeding
1/6/21	CDC	Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine — United States, December 14–23, 2020
1/1/21	CDC	The Advisory Committee on Immunization Practices’ Updated Interim Recommendation for Allocation of COVID-19 Vaccine
12/22/20	CDC	Evidence Table for COVID-19 Vaccines Allocation in Phases 1b and 1c of the Vaccination Program
12/18/20	FDA	Fact Sheet for Recipients and Caregivers of the Moderna COVID-19 Vaccine
12/18/20	FDA	Fact Sheet for Healthcare Providers Administering Moderna Vaccine
12/18/20	FDA	Emergency Use Authorization for Moderna COVID-19 Vaccine
12/13/20	CDC	The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine
12/11/20	CDC	COVID-19 Vaccination Communication Toolkit
12/11/20	CDC	Best Practices on Vaccine Storage and Handling
12/11/20	CDC	COVID-19 Vaccine Training Module for Health Care Providers
12/11/20	FDA	FDA Statement on Vaccines and Related Biological Products Advisory Committee Meeting
12/8/20	Pfizer	Pfizer-BioNTech COVID-19 Vaccine Vaccines and Related Biological Products Advisory Committee Briefing Document
12/8/20	FDA	FDA Briefing Document Pfizer-BioNTech COVID-19 Vaccine-Vaccines and Related Biological Products Advisory Committee Meeting
11/23/20	CDC	The Advisory Committee on Immunization Practices’ Ethical Principles for Allocating Initial Supplies of COVID-19 Vaccine
11/23/20	AstraZeneca	Press Release, Interim Analysis of COVID-19 Vaccine Candidate
11/20/20	FDA	FDA Announces Advisory Committee Meeting to Discuss COVID-19 Vaccine Candidate (Pfizer)
11/20/20	CDC	How CDC Is Making COVID-19 Vaccine Recommendations
11/19/20	FDA	FDA Authorizes Drug Combination for Treatment of COVID-19
11/17/20	FDA	COVID-19 Update: FDA’s Ongoing Commitment to Transparency for COVID-19 EUAs
11/17/20	GAO	Federal Efforts Accelerate Vaccine and Therapeutic Development, but More Transparency Needed on Emergency Use Authorizations
11/16/20	NIH	Promising Interim Results from Clinical Trial of NIH-Moderna COVID-19 Vaccine
11/10/20	AMA	AMA announces vaccine-specific CPT codes for coronavirus immunizations (Pfizer and Moderna)
11/10/20	CMS	Medicare Monoclonal Antibody COVID-19 Infusion Program Instruction
11/10/20	Eli Lilly	Lilly Bamlanivimab Antibody Playbook
11/10/20	HHS, DoD	OWS Therapeutics: Monoclonal Antibody Playbook (updated)
11/9/20	Pfizer	Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study
10/29/20	CDC	COVID-19 Vaccination Program Interim Playbook for Jurisdiction Operations (Version 2.0)
10/6/20	FDA	COVID-19 Vaccines Website
10/6/20	FDA	FDA Briefing Document, Vaccines and Related Biological Products Advisory Committee Meeting (October 22, 2020): Development, authorization and licensure of vaccines to prevent COVID-19
9/23/20	HHS, CDC	Funding from CDC to Jurisdictions for COVID-19 Vaccine Preparedness
9/22/20	CDC	Enhanced Monitoring Programs: Vaccine Safety Assessment for Essential Workers (V-SAFE)
9/16/20	HHS/Operation Warp Speed	Strategy for Distributing a COVID-19 Vaccine
9/16/20	CDC	COVID-19 Vaccination Program Interim Playbook for Jurisdiction Operations
9/3/20	HHS	Guidance for Licensed Pharmacists and Pharmacy Interns Regarding COVID-19 Vaccines and Immunity under the PREP Act
9/1/20	NASEM	Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine
8/19/20	HHS	HH S Expands Access to Childhood Vaccines during COVID-19 Pandemic
8/11/20	HHS	Administration Collaborates with Moderna to Produce 100 Million Doses of COVID-19 Investigational Vaccine
8/7/20	HHS	Fact Sheet: Explaining Operation Warp Speed
8/5/20	HHS, DOD	HHS, DOD Collaborate With Johnson & Johnson to Produce Millions of COVID-19 Investigational Vaccine Doses
7/30/20	FDA	Updated FAQs on the EUA for Remdesivir for Certain Hospitalized COVID-19 Patients
7/22/20	HHS	U.S. Government Engages Pfizer to Produce Millions of Doses of COVID-19 Vaccine
7/21/20	NAM	National Academies Launch Study on Equitable Allocation of a COVID-19 Vaccine
7/16/20	NIH	NIH Directors Blog: Researchers Publish Encouraging Early Data on COVID-19 Vaccine
7/13/20	OIG	U.S. Attorney’s Office Shuts Down Multiple Websites Claiming To Offer Preorders For COVID-19 Vaccine
7/8/20	NIH	NIH launches clinical trials network to test COVID-19 vaccines and other prevention tools
6/30/20	FDA	Guidance for Industry: Development and Licensure Vaccines to Prevent COVID-19
6/16/20	HHS	Fact Sheet: Explaining Operation Warp Speed

Login Failed!

Login Failed!

Action

COVID-19 Vaccine Resources

More COVID-19 Topics

Share

About America’s Essential Hospitals

OUR PAC

CAREERS

Action

QUALITY

INSTITUTE

EDUCATION

ABOUT US

VITAL

POLICY ASSEMBLY

MEDICAID SUMMIT